A phase 2 clinical trial of ACT017

Trial Profile

A phase 2 clinical trial of ACT017

Phase of Trial: Phase II

Latest Information Update: 04 Jan 2018

At a glance

  • Drugs ACT 017 (Primary)
  • Indications Stroke
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Jan 2018 This trial is expected to enroll first stroke patients in June 2018, according to an Acticor Biotech media release.
    • 22 Dec 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top